Primary Myelodysplastic Syndromes-Reference-Cited by-同舟云学术

Primary Myelodysplastic Syndromes

Published:2015-12 Issue:12 Volume:90 Page:1623-1638
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Gangat Naseema,Patnaik Mrinal M.,Begna Kebede,Kourelis Taxiarchis,Al-Kali Aref,Elliott Michelle A.,Hogan William J.,Letendre Louis,Litzow Mark R.,Knudson Ryan A.,Ketterling Rhett P.,Hodnefield Janice M.,Hanson Curtis A.,Pardanani Animesh D.,Tefferi Ayalew

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes;Vardiman;Blood,2009

2. Myelodysplastic syndromes;Tefferi;N Engl J Med,2009

3. Expression and activity of caspases 1 and 3 in myelodysplastic syndromes;Boudard;Leukemia,2000

4. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen;Ebert;Nature,2008

5. Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS;Schneider;Cancer Cell,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting anemia in myeloid neoplasms;American Journal of Hematology;2024-06-05

2. The efficacy and adverse events of arsenic trioxide for the patients with myelodysplastic syndrome: a systematic review and component network meta-analysis;Hematology;2023-10-31

3. 10-year nationwide trends in incidence, treatment patterns, and mortality of patients with myelodysplastic syndromes in Denmark;Leukemia Research;2023-05

4. Bone marrow fibrosis impact on response to azacitidine in myelodysplastic syndromes;Pathology;2022-10

5. Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real‐world setting;American Journal of Hematology;2022-08-12